The PASTEUR Act, introduced in 2020 to need $6 billion, would disrupt the way drugmakers profit from antibiotics as it’s designed for the government to pay an upfront cost to new antibiotic products for an unlimited supply once the FDA approves them.
Among the more than 100 ongoing drug shortages, antibiotics are at more risk of supply hiccups because they don’t make as much revenue as brand-name drugs and million-dollar-generating genomic therapies. Amoxicillin, for example, has been in shortage for months and some companies recently pushed their resupply dates to early 2023.
Another factor is the building resistance to antibiotics, which is partially setoff by providers overprescribing the products when they aren’t necessary.
The Act will likely be sent to Congress’ next session — a delay that can cost healthcare billions of dollars.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
